Orexo Us Inc Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for OREXO US INC, and when can generic versions of OREXO US INC drugs launch?
OREXO US INC has one approved drug.
There are ten US patents protecting OREXO US INC drugs.
There are forty-six patent family members on OREXO US INC drugs in thirty-one countries.
Drugs and US Patents for Orexo Us Inc
Expired US Patents for Orexo Us Inc
Paragraph IV (Patent) Challenges for OREXO US INC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Sublingual Tablets | 8.6 mg/2.1 mg and 11.4 mg/2.9 mg | ➤ Subscribe | 2015-07-24 |
➤ Subscribe | Sublingual tablets | 0.7 mg/0.18 mg | ➤ Subscribe | 2017-05-03 |
➤ Subscribe | Sublingual Tablets | 1.4 mg/0.36 mg and 5.7 mg/1.4 mg | ➤ Subscribe | 2013-10-22 |
➤ Subscribe | Sublingual Tablets | 2.9 mg/7.1 mg | ➤ Subscribe | 2015-12-21 |
International Patents for Orexo Us Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Hungary | E056309 | See Plans and Pricing |
Lithuania | 2915525 | See Plans and Pricing |
Japan | 2010511683 | See Plans and Pricing |
Denmark | 2706986 | See Plans and Pricing |
Mexico | 361757 | See Plans and Pricing |
Poland | 2915525 | See Plans and Pricing |
European Patent Office | 2915525 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.